PXD044829 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | MARK2/MARK3 kinases are catalytic co-dependencies of YAP/TAZ in human cancer |
Description | Human cancer is often caused by dysfunctional developmental pathways, but such mechanisms do not always present clear opportunities for therapeutic intervention. This is exemplified by the Hippo tumor suppressor pathway, which is comprised of a kinase module that restrains the function of YAP/TAZ transcriptional coactivators; a pathway that becomes dysregulated in a wide array of human cancers. Hence, YAP/TAZ hyperactivation is a tumorigenic mechanism and a validated therapeutic target in oncology. In this study, we used a paralog co-targeting genetic screening strategy to identify the kinases MARK2/3 as co-dependencies of YAP/TAZ in diverse cancer contexts. We use biochemical and epistasis experiments to show that MARK2/3 phosphorylate and inhibit the activity of Hippo pathway components NF2, MST1/2, and MAP4Ks, which leads to indirect upstream control of LATS1/2 activity. In addition, MARK2/3 directly phosphorylate YAP/TAZ to shield these coactivators from LATS1/2-mediated inhibition. The net consequence of this multi-level regulation is that YAP/TAZ-dependent human cancers have an absolute requirement for MARK2/3 catalytic activity to sustain tumor cell proliferation and viability. To simulate therapeutic targeting of MARK2/3 in vivo, we adapted the EPIYA-repeat region of the CagA protein from H. pylori as a catalytic inhibitor of MARK2/3, which we show exerts potent anti-tumor activity via on-target mechanisms. Together, these findings reveal MARK2/3 as an obligate catalytic requirement for YAP/TAZ function in human cancer; kinase targets that may allow for novel pharmacology that restores Hippo-mediated tumor suppression. |
HostingRepository | PRIDE |
AnnounceDate | 2024-07-25 |
AnnouncementXML | Submission_2024-07-25_09:45:36.196.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Paolo Cifani |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | phosphorylated residue; monohydroxylated residue |
Instrument | Orbitrap Fusion Lumos |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2023-08-24 08:24:56 | ID requested | |
⏵ 1 | 2024-07-25 09:45:36 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: Phosphorylation Hippo pathway MARK2/3 |
Contact List
Paolo Cifani |
contact affiliation | Mass Spectrometry Shared Resource, Cold Spring Harbor Laboratory |
contact email | cshl.mass.spec@gmail.com |
lab head | |
Paolo Cifani |
contact affiliation | Cold Spring Harbor Laboratory |
contact email | cshl.mass.spec@gmail.com |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/07/PXD044829 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD044829
- Label: PRIDE project
- Name: MARK2/MARK3 kinases are catalytic co-dependencies of YAP/TAZ in human cancer